| Balance sheet (USD) | FY 2026 ended May 31, 2026 | FY 2025 ended May 31, 2025 | FY 2024 ended May 31, 2024 | FY 2023 ended May 31, 2023 | FY 2022 ended May 31, 2022 | FY 2021 ended May 31, 2021 |
|---|---|---|---|---|---|---|
| Cash and equivalents | 1.31M | 2.40M | 4.17M | 9.72M | 5.92M | 4.20M |
| Receivables | 785.0K | 731.0K | 947.0K | 722.0K | 774.0K | 1.46M |
| Inventory | 1.71M | 1.49M | 2.38M | 2.06M | 2.42M | 3.21M |
| Total current assets | 4.02M | 4.88M | 7.73M | 12.80M | 9.43M | 9.23M |
| Property, plant and equipment | 78.0K | 135.0K | 201.0K | 213.0K | 214.0K | 310.5K |
| Goodwill and intangibles | 209.0K | 228.0K | 212.0K | 165.0K | 170.0K | 294.8K |
| Total assets | 6.76M | 5.95M | 9.25M | 14.45M | 11.37M | 11.82M |
| Accounts payable | 377.0K | 295.0K | 560.0K | 344.0K | 736.0K | 431.0K |
| Total current liabilities | 2.48M | 1.74M | 2.20M | 1.95M | 2.01M | 1.30M |
| Total liabilities | 4.13M | 1.84M | 2.66M | 2.73M | 3.05M | 2.59M |
| Retained earnings | -56.94M | -53.17M | -48.20M | -42.22M | -35.08M | -30.55M |
| Shareholders' equity | 2.63M | 4.11M | 6.59M | 11.72M | 8.32M | 9.23M |
From Biomerica Inc.'s 10-K and 10-Q filings with the SEC. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read balance sheet or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.